Aetna considers orthognathic surgery performed primarily to correct unaesthetic facial features to be cosmetic. Isolated chin procedures (mentoplasty/genial osteotomies/ostectomies) performed solely for aesthetic concerns are also considered cosmetic when done as standalone procedures and therefore are not benefits under Aetna medical plans. When chin surgery is combined with other procedures, the cosmetic determination depends on the overall indication and whether functional impairment is being addressed.

Systematic reviews and trials informing this policy often applied study-specific eligibility and exclusion criteria; for example, reviews of orthodontic treatments and TMD excluded short-term splint-only studies and direct joint exploration procedures, and many included only randomized trials or higher-quality observational designs. These methodological exclusions affect the generalizability of published findings and are the basis for classifying certain indications or techniques as experimental when evidence of effectiveness is inadequate.

Some evidence syntheses and trials excluded patients with syndromic disorders and those with cleft lip/palate from analyses (for example, systematic reviews comparing biodegradable versus titanium fixation), limiting applicability of those results to non-syndromic populations.

This Clinical Policy Bulletin provides a partial, general description of plan or program benefits and is intended to assist in administering benefits. It does not constitute a contract or guarantee of coverage. Participating providers remain responsible for medical advice and treatment, and this bulletin may be updated or changed.

Orthognathic surgery may be considered medically necessary for speech impairments that accompany severe cleft deformity when the procedure is intended to improve speech and facial form. By contrast, surgery for correction of sibilant distortions or other speech quality distortions (for example, hyper-nasal or hypo-nasal speech) that do not produce demonstrable functional impairment is considered not medically necessary.

The policy notes limited and low-quality evidence for several indications; where published studies are small, observational, heterogeneous, or exclude key patient groups, evidence is insufficient to support orthognathic surgery as an established treatment (for example, as primary therapy for TMD or for many speech/articulation disorders). Because of these evidence limitations, several indications and techniques are described as experimental/investigational or lacking support rather than being explicitly labeled with universal "not medically necessary" language.

Within the document excerpts reviewed there are no additional explicit statements that label other procedures or indications as universally not medically necessary; where the policy uses terms such as "insufficient evidence" or "experimental/investigational," reviewers should rely on the specific exclusions and criteria sections for coverage determinations.

Orthognathic surgery involves revision of the upper and/or lower jaw (maxilla and/or mandible) using ostectomy, osteotomy, or osteoplasty to correct skeletal jaw and craniofacial relationships that produce functional impairment. These procedures reposition the facial skeleton—with or without bone/cartilage grafts, plates, screws, and surgical splints—to restore occlusion and improve chewing, speaking, or swallowing when orthodontic treatment alone is inadequate.